Cresco Labs (CRLBF) Gains from Investment Securities (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Gains from Investment Securities came in at -$341000.0 in Q1 2026, down 124.75% on a QoQ basis from $1.4 million in Q4 2024.
Cresco Labs (CRLBF) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Gains from Investment Securities data on file, last reported at -$341000.0 in Q1 2026.
- Quarterly Gains from Investment Securities changed N/A year-over-year to -$341000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $549000.0 (changed N/A YoY) and the FY2025 annual result came in at -$1.1 million, down 241.67% from the prior year.
- Gains from Investment Securities fell to -$341000.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $5.7 million in Q1 2022 to a low of -$488000.0 in Q2 2024.
- A 4-year average of $1.2 million and a median of $547000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities plunged 49.0% — and 2024, when it tumbled 109.14%.
- Tracing CRLBF's Gains from Investment Securities over 4 years: stood at $5.7 million in 2022, then sank by 78.75% to $1.2 million in 2023, then grew by 14.45% to $1.4 million in 2024, then tumbled by 124.75% to -$341000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$341000.0 (Q1 2026), $1.4 million (Q4 2024), and -$488000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -341,000.00 |
| Mar 31, 2026 | -341,000.00 |
| Dec 31, 2024 | 1.38 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Jun 30, 2024 | -488,000.00 |
| Jun 30, 2024 | -488,000.00 |
| Mar 31, 2024 | -110,000.00 |
| Mar 31, 2024 | -110,000.00 |
| Mar 31, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Mar 31, 2022 | 5.67 Mn |
| Mar 31, 2022 | 5.67 Mn |
| Sep 30, 2021 | -15.08 Mn |
| Sep 30, 2021 | -15.08 Mn |
| Jun 30, 2021 | -2.98 Mn |
| Jun 30, 2021 | -2.98 Mn |
| Mar 31, 2021 | 11.11 Mn |
| Mar 31, 2021 | 11.11 Mn |
| Dec 31, 2020 | 7.46 Mn |
| Dec 31, 2020 | 7.46 Mn |